Skip to main content
Top
Published in: BMC Endocrine Disorders 1/2019

Open Access 01-12-2019 | Insulins | Research article

Self-reported hypoglycemia in adult diabetic patients in East Gojjam, Northwest Ethiopia: institution based cross-sectional study

Authors: Gashayeneh Genetu Tiruneh, Nurilign Abebe, Getenet Dessie

Published in: BMC Endocrine Disorders | Issue 1/2019

Login to get access

Abstract

Background

Hypoglycemia presents a barrier to optimum diabetes management and it is related to a negative impact on health-related quality of life, healthcare resource use, and work productivity. Despite the fact that the magnitude of hypoglycemia and factors associated with hypoglycemia in diabetic population were demonstrated in clinical trial settings; there is no adequate evidence concerning to the problem in real-world settings, in particular in the study area. The aim of the study was to assess the magnitude of hypoglycemia and factors associated with hypoglycemia among adult diabetic patients attending chronic follow up clinic at Debre Markos referral hospital, East Gojjam Zone, Northwest Ethiopia, 2017.

Methods

An institution-based cross-sectional study was conducted among 394 sampled diabetic patients who were selected through systematic random sampling technique at Debre Markos referral hospital. Data were collected using structured interviewer-administered questionnaire. The collected data were entered and cleared using epi-data version 3.1 and analyzed by SPSS version 20. We used bivariate and multivariate logistic regression models to identify variables for multivariate analysis and to identify associated factors for hypoglycemia, respectively.

Result

The study revealed that 279(70.8%) of diabetic patients had experienced hypoglycemic event since the diagnosis of diabetes. Patients with type 1 diabetes were more likely to have hypoglycemia as compared with type 2 diabetic patients. The factors found to be significantly associated with hypoglycemia included type 2 diabetes (AOR 0.34, 95%CI: 0.14, 0.82), duration of diabetes from 10 to 14 years (AOR 6.34, 95%CI: 2.12, 18.96) and insulin therapy (AOR 4.93, 95%CI: 2.05, 11.86). Diabetic patients who are government employees (AOR = 0.29, 95%CI: 0.11, 0.78) were less likely to have hypoglycemia when compared to farmers.

Conclusion

The magnitude of hypoglycemia was found to be high and significantly associated with occupation, type of diabetes mellitus, type of medication and duration of diabetes mellitus since diagnosis. Therefore, attention is needed from health-related governmental organizations and health care providers to decrease the burden of hypoglycemia and to address the major contributing factors.
Literature
1.
go back to reference Global status report on noncommunicable diseases In.: WHO; 2014. Global status report on noncommunicable diseases In.: WHO; 2014.
2.
go back to reference Diabetes Atlas IDF. In. In: 7th edn: international Diabetes federation; 2015. Diabetes Atlas IDF. In. In: 7th edn: international Diabetes federation; 2015.
3.
4.
go back to reference Seaquist ER, Anderson J, Childs B, Cryer P, Dagogo-Jack S, Fish L, Heller SR, Rodriguez H, Rosenzweig J, Vigersky R. Hypoglycemia and Diabetes: a report of a workgroup of the American Diabetes Association and the Endocrine Society. Diabetes Care. 2013;36:1384–95.CrossRef Seaquist ER, Anderson J, Childs B, Cryer P, Dagogo-Jack S, Fish L, Heller SR, Rodriguez H, Rosenzweig J, Vigersky R. Hypoglycemia and Diabetes: a report of a workgroup of the American Diabetes Association and the Endocrine Society. Diabetes Care. 2013;36:1384–95.CrossRef
5.
go back to reference UKProspectiveDiabetesStudy (UKPDS)Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998;352(9131):837–53.CrossRef UKProspectiveDiabetesStudy (UKPDS)Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998;352(9131):837–53.CrossRef
6.
go back to reference TheDiabetesControlComplicationsTrialResearchGroup. The effect of intensive treatment of Diabetes on the development and progression of long-term complications in insulin-dependent Diabetes mellitus. N Engl J Med. 1993;329(14):977–86.CrossRef TheDiabetesControlComplicationsTrialResearchGroup. The effect of intensive treatment of Diabetes on the development and progression of long-term complications in insulin-dependent Diabetes mellitus. N Engl J Med. 1993;329(14):977–86.CrossRef
7.
go back to reference Ahrén B. Avoiding hypoglycemia: a key to success for glucose-lowering therapy in type 2 diabetes. Vasc Health Risk Manag. 2013;9:155–63.CrossRef Ahrén B. Avoiding hypoglycemia: a key to success for glucose-lowering therapy in type 2 diabetes. Vasc Health Risk Manag. 2013;9:155–63.CrossRef
8.
go back to reference Elliott L, Fidler C, Ditchfield A, Stissing T. Hypoglycemia event rates: a comparison between real-world data and randomized controlled trial populations in insulin-treated Diabetes. Diabetes Ther. 2016;7:45–60.CrossRef Elliott L, Fidler C, Ditchfield A, Stissing T. Hypoglycemia event rates: a comparison between real-world data and randomized controlled trial populations in insulin-treated Diabetes. Diabetes Ther. 2016;7:45–60.CrossRef
9.
go back to reference Tesfaye N, Seaquist ER. Neuroendocrine responses to hypoglycemia. Ann N Y Acad Sci. 2010;1212:12–28.CrossRef Tesfaye N, Seaquist ER. Neuroendocrine responses to hypoglycemia. Ann N Y Acad Sci. 2010;1212:12–28.CrossRef
10.
go back to reference Bronstone A, Graham C. The potential cost implications of averting severe hypoglycemic events requiring hospitalization in high-risk adults with type 1 Diabetes using real-time continuous glucose monitoring. J Diabetes Sci Technol. 2016;10(4):905–13.CrossRef Bronstone A, Graham C. The potential cost implications of averting severe hypoglycemic events requiring hospitalization in high-risk adults with type 1 Diabetes using real-time continuous glucose monitoring. J Diabetes Sci Technol. 2016;10(4):905–13.CrossRef
11.
go back to reference Shafiee G, Mohajeri-Tehrani M, Pajouhi M, Larijani B. The importance of hypoglycemia in diabetic patients. Journal of Diabetes & Metabolic Disorders. 2012;11:17.CrossRef Shafiee G, Mohajeri-Tehrani M, Pajouhi M, Larijani B. The importance of hypoglycemia in diabetic patients. Journal of Diabetes & Metabolic Disorders. 2012;11:17.CrossRef
12.
go back to reference Zoungas S, Patel A, Chalmers J, de Galan B, Qiang Li MB, Billot L, Woodward M, Ninomiya T, Neal B, MacMahon S, et al. Severe hypoglycemia and risks of vascular events and death. N Engl J Med. 2010;363:1410–8.CrossRef Zoungas S, Patel A, Chalmers J, de Galan B, Qiang Li MB, Billot L, Woodward M, Ninomiya T, Neal B, MacMahon S, et al. Severe hypoglycemia and risks of vascular events and death. N Engl J Med. 2010;363:1410–8.CrossRef
13.
go back to reference Emral R, Pathan F, Cortés CAY, El-Hefnawy MH, Goh S-Y, Gómez AM, Murphy A, Abusnana S, Rudijanto A, Jain A. Self-reported hypoglycemia in insulin-treated patients with diabetes: results from an international survey on 7289 patients from nine countries. Diabetes Res Clin Pract. 2017;134:17–28.CrossRef Emral R, Pathan F, Cortés CAY, El-Hefnawy MH, Goh S-Y, Gómez AM, Murphy A, Abusnana S, Rudijanto A, Jain A. Self-reported hypoglycemia in insulin-treated patients with diabetes: results from an international survey on 7289 patients from nine countries. Diabetes Res Clin Pract. 2017;134:17–28.CrossRef
14.
go back to reference Emral R, Tetiker T, Sahin I, Sari R, Kaya A, Yetkin İ, Cil SU, Tütüncü NB. An international survey on hypoglycemia among insulin-treated type I and type II diabetes patients: Turkey cohort of the non-interventional IO HAT study. BMC Endocr Disord. 2018;18(1):9.CrossRef Emral R, Tetiker T, Sahin I, Sari R, Kaya A, Yetkin İ, Cil SU, Tütüncü NB. An international survey on hypoglycemia among insulin-treated type I and type II diabetes patients: Turkey cohort of the non-interventional IO HAT study. BMC Endocr Disord. 2018;18(1):9.CrossRef
15.
go back to reference Cryer PE. The barrier of hypoglycemia in Diabetes. DIABETES. 2008;57:3169–76.CrossRef Cryer PE. The barrier of hypoglycemia in Diabetes. DIABETES. 2008;57:3169–76.CrossRef
16.
go back to reference Henderson JN, Allen KV, Deary IJ, Frier BM. Hypoglycaemia in insulin-treated type 2 diabetes: frequency, symptoms and impaired awareness. Diabet Med. 2003;20:1016–21.CrossRef Henderson JN, Allen KV, Deary IJ, Frier BM. Hypoglycaemia in insulin-treated type 2 diabetes: frequency, symptoms and impaired awareness. Diabet Med. 2003;20:1016–21.CrossRef
17.
go back to reference Wako A, Belay S, Feleke Y, Kebede T. Assessment of the magnitude, severity and associated factors of hypoglycemia in diabetic patients attending National Diabetes Referral Clinic at Tikur Anbessa hospital, Addis Ababa, Ethiopia. Journal of Diabetes and Metabolism. 2017;8(5). Wako A, Belay S, Feleke Y, Kebede T. Assessment of the magnitude, severity and associated factors of hypoglycemia in diabetic patients attending National Diabetes Referral Clinic at Tikur Anbessa hospital, Addis Ababa, Ethiopia. Journal of Diabetes and Metabolism. 2017;8(5).
18.
go back to reference Bonaventura A, Montecucco F, Dallegri F. Update on strategies limiting iatrogenic hypoglycemia. Endocrine Connections. 2015;4:R37–45.CrossRef Bonaventura A, Montecucco F, Dallegri F. Update on strategies limiting iatrogenic hypoglycemia. Endocrine Connections. 2015;4:R37–45.CrossRef
19.
go back to reference . In. Medical Director's Office: Debre Markos Referral Hospital; 2017. . In. Medical Director's Office: Debre Markos Referral Hospital; 2017.
20.
go back to reference Ostenson CG, Geelhoed-Duijvestijn P, Lahtela J, Weitgasser R, Jensen MM, Pedersen-Bjergaard U. Self-reported non-severe hypoglycaemic events in Europe. Diabet Med. 2014;31:92–101.CrossRef Ostenson CG, Geelhoed-Duijvestijn P, Lahtela J, Weitgasser R, Jensen MM, Pedersen-Bjergaard U. Self-reported non-severe hypoglycaemic events in Europe. Diabet Med. 2014;31:92–101.CrossRef
21.
go back to reference Leese GP, Wang J, Broomhall J, Kelly P, Marsden A, Morrison W, Frier BM, Morris AD. Frequency of severe hypoglycemia requiring emergency treatment in type 1 and type 2 Diabetes:a population-based study of health service resource use. Diabetes Care. 2003;26:1176–80.CrossRef Leese GP, Wang J, Broomhall J, Kelly P, Marsden A, Morrison W, Frier BM, Morris AD. Frequency of severe hypoglycemia requiring emergency treatment in type 1 and type 2 Diabetes:a population-based study of health service resource use. Diabetes Care. 2003;26:1176–80.CrossRef
22.
go back to reference Weitgasser R, Lopes S. Self-reported frequency and impact of hypoglycaemic events in insulin-treated diabetic patients in Austria. Wien Klin Wochenschr. 2015;127:36–44.CrossRef Weitgasser R, Lopes S. Self-reported frequency and impact of hypoglycaemic events in insulin-treated diabetic patients in Austria. Wien Klin Wochenschr. 2015;127:36–44.CrossRef
23.
go back to reference Frier BM, Jensen MM, Chubb BD. Hypoglycaemia in adults with insulin-treated diabetes in the UK: self-reported frequency and effects. Diabet Med. 2016;33:1125–32.CrossRef Frier BM, Jensen MM, Chubb BD. Hypoglycaemia in adults with insulin-treated diabetes in the UK: self-reported frequency and effects. Diabet Med. 2016;33:1125–32.CrossRef
Metadata
Title
Self-reported hypoglycemia in adult diabetic patients in East Gojjam, Northwest Ethiopia: institution based cross-sectional study
Authors
Gashayeneh Genetu Tiruneh
Nurilign Abebe
Getenet Dessie
Publication date
01-12-2019
Publisher
BioMed Central
Published in
BMC Endocrine Disorders / Issue 1/2019
Electronic ISSN: 1472-6823
DOI
https://doi.org/10.1186/s12902-019-0341-z

Other articles of this Issue 1/2019

BMC Endocrine Disorders 1/2019 Go to the issue